Intra-Cellular Therapies Inc. buy Mizuho
Start price
21.06.24
/
50%
€71.00
Target price
21.06.25
€93.48
Performance (%)
-9.86%
Price
02.07.24
€64.00
Summary
This prediction is currently active. With a performance of -9.86%, the BUY prediction for Intra-Cellular Therapies Inc. by Mizuho is down slightly. This prediction currently runs until 21.06.25. The prediction end date can be changed by Mizuho at any time. Mizuho has 50% into this predictionPerformance without dividends (%)
Name | 1w |
---|---|
Intra-Cellular Therapies Inc. | -5.882% |
iShares Core DAX® | -0.145% |
iShares Nasdaq 100 | 1.296% |
iShares Nikkei 225® | 1.282% |
iShares S&P 500 | 0.442% |
Comments by Mizuho for this prediction
In the thread Intra-Cellular Therapies Inc. diskutieren
Intra-Cellular Therapies, Inc. (NASDAQ: ITCI) had its price target raised by analysts at Mizuho from $96.00 to $100.00. They now have a "buy" rating on the stock.
Ratings data for ITCI provided by MarketBeat
Stopped prediction by Mizuho for Intra-Cellular Therapies Inc.
Intra-Cellular Therapies Inc.
Start price
Target price
Perf. (%)
€70.50
22.04.24
22.04.24
€90.20
22.04.25
22.04.25
-9.22%
02.07.24
02.07.24
Intra-Cellular Therapies Inc.
Start price
Target price
Perf. (%)
€69.30
17.02.24
17.02.24
€76.07
17.02.25
17.02.25
-9.09%
02.07.24
02.07.24